Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial

2020 ◽  
Vol 8 (4) ◽  
pp. 313-324 ◽  
Author(s):  
Nicklas J Johansen ◽  
Thomas F Dejgaard ◽  
Asger Lund ◽  
Camilla Schlüntz ◽  
Christian S Frandsen ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Glycaemic Control ◽  
Controlled Trial ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Short Acting ◽  
Meal Time

Effect of short‐acting exenatide administered three times daily on markers of cardiovascular disease in type 1 diabetes: A randomized double‐blind placebo‐controlled trial

2020 ◽  
Vol 22 (9) ◽  
pp. 1639-1647
Author(s):  
Nicklas J. Johansen ◽  
Thomas F. Dejgaard ◽  
Asger Lund ◽  
Camilla Schlüntz ◽  
Emil L. Larsen ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Type 1 Diabetes ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Short Acting
Sign in / Sign up

Export Citation Format

Share Document